Subscribe
Promise & Peril: The Digital Biomarker Revolution with Chris Lew, Senior Associate at DeciBio Consulting

Outcomes Rocket

Promise & Peril: The Digital Biomarker Revolution with Chris Lew, Senior Associate at DeciBio Consulting

June 4, 2020
ADVERTISEMENT
DOCSF21

Promise & Peril: The Digital Biomarker Revolution with Chris Lew, Senior Associate at DeciBio Consulting

In this episode, Chris Lew, Senior Associate at DeciBio Consulting, shares his company’s focus on driving disruption and innovation in the precision medicine space. He also talks about his passion for digital health and delivering impactful solutions based on customer needs. Chris is excited about the digital biomarker revolution and lays out the potential benefits of this technology to health care.
We hope you’ll enjoy this interview with Chris as much as we did.

https://outcomesrocket.health/decibio/2020/06/

ADVERTISEMENT
DOCSF21

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Subscribe to Health Podcast Network

Proudly supported by:

HealthXLGet Health
cover
Javier Lozano - Market-Creating Innovation for Diabetes Care an inspiring conversation with Javier Lozano, Founder and CEO of Clínicas del Azúcar, a growing chain of "one-stop shops" for diabetes care in Mexico.